Pharmacologic treatment of attention deficit hyperactivity disorder.
This article describes the role of psychostimulant medication in the treatment of attention deficit hyperactivity disorder. Included are the drugs' putative mechanisms of action, pharmacology, toxicology, indications for their use, short-term and long-term actions, adverse effects, specific dosing regimens, therapeutic monitoring techniques, alternative medications, and drug interactions.
Columbia University, Columbia Presbyterian Medical Center, New York, New York.
L L
LL
Greenhill
D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy* / Q000378:metabolism / Q000523:psychology; D000697:Central Nervous System Stimulants / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003000:Clonidine / Q000009:adverse effects / Q000627:therapeutic use; D003891:Desipramine / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008774:Methylphenidate / Q000378:metabolism / Q000627:therapeutic use
D000697:Central Nervous System Stimulants; D008774:Methylphenidate; D003000:Clonidine; D003891:Desipramine